342 related articles for article (PubMed ID: 20368557)
1. Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival.
Liu Y; Shete S; Etzel CJ; Scheurer M; Alexiou G; Armstrong G; Tsavachidis S; Liang FW; Gilbert M; Aldape K; Armstrong T; Houlston R; Hosking F; Robertson L; Xiao Y; Wiencke J; Wrensch M; Andersson U; Melin BS; Bondy M
J Clin Oncol; 2010 May; 28(14):2467-74. PubMed ID: 20368557
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of DNA double-strand break repair pathway genes and glioma susceptibility.
Zhao P; Zou P; Zhao L; Yan W; Kang C; Jiang T; You Y
BMC Cancer; 2013 May; 13():234. PubMed ID: 23663450
[TBL] [Abstract][Full Text] [Related]
3. Association between RTEL1, PHLDB1, and TREH Polymorphisms and Glioblastoma Risk: A Case-Control Study.
Yang B; Heng L; Du S; Yang H; Jin T; Lang H; Li S
Med Sci Monit; 2015 Jul; 21():1983-8. PubMed ID: 26156397
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma.
Liu Y; Zhou K; Zhang H; Shugart YY; Chen L; Xu Z; Zhong Y; Liu H; Jin L; Wei Q; Huang F; Lu D; Zhou L
Hum Mutat; 2008 Mar; 29(3):381-9. PubMed ID: 18165945
[TBL] [Abstract][Full Text] [Related]
5. CCDC26, CDKN2BAS, RTEL1 and TERT Polymorphisms in pediatric brain tumor susceptibility.
Adel Fahmideh M; Lavebratt C; Schüz J; Röösli M; Tynes T; Grotzer MA; Johansen C; Kuehni CE; Lannering B; Prochazka M; Schmidt LS; Feychting M
Carcinogenesis; 2015 Aug; 36(8):876-82. PubMed ID: 26014354
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in double-strand breaks repair genes are associated with impaired fertility in Chinese population.
Ji G; Yan L; Liu W; Huang C; Gu A; Wang X
Reproduction; 2013 May; 145(5):463-70. PubMed ID: 23630330
[TBL] [Abstract][Full Text] [Related]
7. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
[TBL] [Abstract][Full Text] [Related]
8. LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patients.
Mock A; Geisenberger C; Orlik C; Warta R; Schwager C; Jungk C; Dutruel C; Geiselhart L; Weichenhan D; Zucknick M; Nied AK; Friauf S; Exner J; Capper D; Hartmann C; Lahrmann B; Grabe N; Debus J; von Deimling A; Popanda O; Plass C; Unterberg A; Abdollahi A; Schmezer P; Herold-Mende C
Int J Cancer; 2016 Jul; 139(2):424-32. PubMed ID: 26934681
[TBL] [Abstract][Full Text] [Related]
9. DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome.
Reeves SG; Meldrum C; Groombridge C; Spigelman A; Suchy J; Kurzawski G; Lubinski J; Scott RJ
Cancer Epidemiol; 2012 Apr; 36(2):183-9. PubMed ID: 21974800
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of polymorphisms of DNA double-strand break repair genes XRCC5, LIG4 and glioma].
He P; Li R; Luo W; Meng L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Jun; 39(6):641-645. PubMed ID: 35773772
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma.
Scheurer ME; Amirian E; Cao Y; Gilbert MR; Aldape KD; Kornguth DG; El-Zein R; Bondy ML
Clin Cancer Res; 2008 Oct; 14(20):6640-6. PubMed ID: 18927306
[TBL] [Abstract][Full Text] [Related]
12. Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients.
Viana-Pereira M; Moreno DA; Linhares P; Amorim J; Nabiço R; Costa S; Vaz R; Reis RM
Mol Biol Rep; 2020 Feb; 47(2):877-886. PubMed ID: 31721021
[TBL] [Abstract][Full Text] [Related]
13. Association of LIG4 and XRCC4 gene polymorphisms with the risk of human glioma in a Chinese population.
Su Y; Qi S; Dou C; Shuang L; Yan H
Int J Clin Exp Pathol; 2015; 8(2):2057-62. PubMed ID: 25973104
[TBL] [Abstract][Full Text] [Related]
14. RTEL1 tagging SNPs and haplotypes were associated with glioma development.
Li G; Jin T; Liang H; Zhang Z; He S; Tu Y; Yang H; Geng T; Cui G; Chen C; Gao G
Diagn Pathol; 2013 May; 8():83. PubMed ID: 23683922
[TBL] [Abstract][Full Text] [Related]
15. Association and interactions between DNA repair gene polymorphisms and adult glioma.
Liu Y; Scheurer ME; El-Zein R; Cao Y; Do KA; Gilbert M; Aldape KD; Wei Q; Etzel C; Bondy ML
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):204-14. PubMed ID: 19124499
[TBL] [Abstract][Full Text] [Related]
16. TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme.
Kraus JA; Wenghoefer M; Glesmann N; Mohr S; Beck M; Schmidt MC; Schröder R; Berweiler U; Roggendorf W; Diete S; Dietzmann K; Heuser K; Müller B; Fimmers R; von Deimling A; Schlegel U
J Neurooncol; 2001 May; 52(3):263-72. PubMed ID: 11519857
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival.
Michaelsen SR; Urup T; Olsen LR; Broholm H; Lassen U; Poulsen HS
J Neurooncol; 2018 May; 137(3):533-542. PubMed ID: 29305787
[TBL] [Abstract][Full Text] [Related]
18. A robust two-gene signature for glioblastoma survival prediction.
Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB
J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992
[TBL] [Abstract][Full Text] [Related]
19. LIG4 and RAD52 DNA repair genes polymorphisms and systemic lupus erythematosus.
De Azevêdo Silva J; Pancotto JA; Donadi EA; Crovella S; Sandrin-Garcia P
Mol Biol Rep; 2014; 41(4):2249-56. PubMed ID: 24415301
[TBL] [Abstract][Full Text] [Related]
20. CCDC26 gene polymorphism and glioblastoma risk in the Han Chinese population.
Wei XB; Jin TB; Li G; Geng TT; Zhang JY; Chen CP; Gao GD; Chen C; Gong YK
Asian Pac J Cancer Prev; 2014; 15(8):3629-33. PubMed ID: 24870769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]